Obesity-related indices are associated with albuminuria and advanced kidney disease in type 2 diabetes mellitus

References

• Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: approaches and initiatives – a position statement from kidney disease improving global outcomes. Kidney Int. 2007;72(3):247–259.
   PubMed Web of Science ®Google Scholar
• Saran R, Robinson B, Abbott KC, et al. US renal data system 2018 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2019;73(3 Suppl 1):A7–A8.
   PubMed Web of Science ®Google Scholar
• Palsson R, Patel UD. Cardiovascular complications of diabetic kidney disease. Adv Chronic Kidney Dis. 2014;21(3):273–280.
   PubMed Web of Science ®Google Scholar
• Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384(9945):766–781.
   PubMed Web of Science ®Google Scholar
• , Lu Y, Hajifathalian K, Global Burden of Metabolic Risk Factors for Chronic Diseases C, et al. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet. 2014;383(9921):970–983.
   PubMed Web of Science ®Google Scholar
• Martin WP, Bauer J, Coleman J, et al. Obesity is common in chronic kidney disease and associates with greater antihypertensive usage and proteinuria: evidence from a cross-sectional study in a tertiary nephrology centre. Clin Obes. 2020;10(6):e12402.
   PubMed Web of Science ®Google Scholar
• Chang AR, Grams ME, Navaneethan SD. Bariatric surgery and kidney-related outcomes. Kidney Int Rep. 2017;2(2):261–270.
   PubMed Web of Science ®Google Scholar
• Kahn HS. The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005;5(1):26.
   PubMedGoogle Scholar
• Thomas DM, Bredlau C, Bosy-Westphal A, et al. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obesity (Silver Spring). 2013;21(11):2264–2271.
   PubMed Web of Science ®Google Scholar
• Valdez R. A simple model-based index of abdominal adiposity. J Clin Epidemiol. 1991;44(9):955–956.
   PubMed Web of Science ®Google Scholar
• Amato MC, Giordano C, Galia M, for the AlkaMeSy Study Group, et al. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920–922.
   PubMed Web of Science ®Google Scholar
• Bergman RN, Stefanovski D, Buchanan TA, et al. A better index of body adiposity. Obesity (Silver Spring, Md.). 2011;19(5):1083–1089.
   PubMed Web of Science ®Google Scholar
• Guerrero-Romero F, Rodríguez-Morán M. Abdominal volume index. An anthropometry-based index for estimation of obesity is strongly related to impaired glucose tolerance and type 2 diabetes mellitus. Arch Med Res. 2003;34(5):428–432.
   PubMed Web of Science ®Google Scholar
• Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS One. 2012;7(7):e39504.
   PubMed Web of Science ®Google Scholar
• Guerrero-Romero F, Simental-Mendia LE, Gonzalez-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–3351.
   PubMed Web of Science ®Google Scholar
• Hsu CY, McCulloch CE, Iribarren C, et al. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144(1):21–28.
   PubMed Web of Science ®Google Scholar
• Herrington WG, Smith M, Bankhead C, et al. Body-mass index and risk of advanced chronic kidney disease: prospective analyses from a primary care cohort of 1.4 million adults in England. PLoS One. 2017;12(3):e0173515.
   PubMed Web of Science ®Google Scholar
• Lam BC, Koh GC, Chen C, et al. Comparison of body mass index (BMI), body adiposity index (BAI), waist circumference (WC), waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) as predictors of cardiovascular disease risk factors in an adult population in Singapore. PLoS One. 2015;10(4):e0122985.
   PubMed Web of Science ®Google Scholar
• Alshamiri MQ, Mohd AHF, Al-Qahtani SS, et al. Waist-to-height ratio (WHtR) in predicting coronary artery disease compared to body mass index and waist circumference in a single center from Saudi Arabia. Cardiol Res Pract. 2020;2020:1–6.
   Web of Science ®Google Scholar
• Motamed N, Rabiee B, Hemasi GR, et al. Body roundness index and waist-to-height ratio are strongly associated with non-alcoholic fatty liver disease: a population-based study. Hepat Mon. 2016;16(9):e39575.
   PubMed Web of Science ®Google Scholar
• Vickery S, Stevens PE, Dalton RN, et al. Does the ID-MS traceable MDRD equation work and is it suitable for use with compensated Jaffe and enzymatic creatinine assays? Nephrol Dial Transplant. 2006;21(9):2439–2445.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, for the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration), et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
   PubMed Web of Science ®Google Scholar
• Pinto-Sietsma SJ, Navis G, Janssen WM, et al. A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis. 2003;41(4):733–741.
   PubMed Web of Science ®Google Scholar
• Kawar B, Bello AK, El Nahas AM. High prevalence of microalbuminuria in the overweight and obese population: data from a UK population screening programme. Nephron Clin Pract. 2009;112(3):c205–c212.
   PubMedGoogle Scholar
• Zhang XH, Zhang M, He J, et al. Comparison of anthropometric and atherogenic indices as screening tools of metabolic syndrome in the Kazakh adult population in Xinjiang. Int J Environ Res Public Health. 2016;13(4):428.
   PubMed Web of Science ®Google Scholar
• Ma CM, Lu N, Wang R, et al. Three novel obese indicators perform better in monitoring management of metabolic syndrome in type 2 diabetes. Sci Rep. 2017;7(1):9843.
   PubMedGoogle Scholar
• Dai D, Chang Y, Chen Y, et al. Visceral adiposity index and lipid accumulation product index: two alternate body indices to identify chronic kidney disease among the rural population in northeast China. Int J Environ Res Public Health. 2016;13(12):1231.
   Web of Science ®Google Scholar
• Liu L, Xia R, Song X, et al. Association between the triglyceride-glucose index and diabetic nephropathy in patients with type 2 diabetes: a cross-sectional study. J Diabetes Investig. 2021;12(4):557–565.
   PubMed Web of Science ®Google Scholar
• Chiu H, Tsai HJ, Huang JC, et al. Associations between triglyceride-glucose index and micro- and macro-angiopathies in type 2 diabetes mellitus. Nutrients. 2020;12(2):328.
   Web of Science ®Google Scholar
• Kasiske BL, Cleary MP, O'Donnell MP, et al. Effects of genetic obesity on renal structure and function in the Zucker rat. J Lab Clin Med. 1985;106(5):598–604.
   PubMed Web of Science ®Google Scholar
• Henegar JR, Bigler SA, Henegar LK, et al. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol. 2001;12(6):1211–1217.
   PubMed Web of Science ®Google Scholar
• Fischer-Posovszky P, Wabitsch M, Hochberg Z. Endocrinology of adipose tissue – an update. Horm Metab Res. 2007;39(5):314–321.
   PubMed Web of Science ®Google Scholar
• Lee J, Lee S, Zhang H, et al. Interaction of IL-6 and TNF-α contributes to endothelial dysfunction in type 2 diabetic mouse hearts. PLoS One. 2017;12(11):e0187189.
   PubMed Web of Science ®Google Scholar
• Munkhaugen J, Lydersen S, Wideroe TE, et al. Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway. Am J Kidney Dis. 2009;54(4):638–646.
   PubMed Web of Science ®Google Scholar
• Ejerblad E, Fored CM, Lindblad P, et al. Obesity and risk for chronic renal failure. JASN. 2006;17(6):1695–1702.
   Web of Science ®Google Scholar
• Cao Y, Sun G, Liu R, et al. Plasma triglyceride levels and central obesity predict the development of kidney injury in Chinese community older adults. Ren Fail. 2019;41(1):946–953.
   PubMed Web of Science ®Google Scholar
• Wanner C, Jager KJ. Kidneys do not like excess body fat. Lancet Diabetes Endocrinol. 2015;3(9):669–671.
   PubMed Web of Science ®Google Scholar
• Stenvinkel P, Zoccali C, Ikizler TA. Obesity in CKD – What should nephrologists know? J Am Soc Nephrol. 2013;24(11):1727–1736.
   PubMed Web of Science ®Google Scholar
• Martin WP, Le Roux CW. Comment on: metabolic surgery improves renal injury independent of weight loss: a meta-analysis. Surg Obes Relat Dis. 2019;15(6):1020–1023.
   PubMed Web of Science ®Google Scholar
• Martin WP, White J, Lopez-Hernandez FJ, et al. Metabolic surgery to treat obesity in diabetic kidney disease, chronic kidney disease, and end-stage kidney disease; what are the unanswered questions? Front Endocrinol (Lausanne). 2020;11:289.
   PubMed Web of Science ®Google Scholar
• Mallamaci F, Tripepi G. Obesity and CKD progression: hard facts on fat CKD patients. Nephrol Dial Transplant. 2013;28(Suppl 4):iv105–iv108.
   PubMedGoogle Scholar
• Ruan XZ, Varghese Z, Moorhead JF. An update on the lipid nephrotoxicity hypothesis. Nat Rev Nephrol. 2009;5(12):713–721.
   PubMed Web of Science ®Google Scholar
• Ruster C, Wolf G. The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases. Semin Nephrol. 2013;33(1):44–53.
   PubMed Web of Science ®Google Scholar
• de Vries AP, Ruggenenti P, Ruan XZ, ERA-EDTA Working Group Diabesity, et al. Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease. Lancet Diabetes Endocrinol. 2014;2(5):417–426.
   PubMed Web of Science ®Google Scholar
• Tsuboi N, Utsunomiya Y, Kanzaki G, et al. Low glomerular density with glomerulomegaly in obesity-related glomerulopathy. Clin J Am Soc Nephrol. 2012;7(5):735–741.
   PubMed Web of Science ®Google Scholar
• Bamba R, Okamura T, Hashimoto Y, et al. The visceral adiposity index is a predictor of incident chronic kidney disease: a population-based longitudinal study. Kidney Blood Press Res. 2020;45(3):407–418.
   PubMed Web of Science ®Google Scholar
• Xiao H, Xiong C, Shao X, et al. Visceral adiposity index and chronic kidney disease in a non-diabetic population: a cross-sectional study. DMSO. 2020;13:257–265.
   Google Scholar
• Correa MM, Thume E, De Oliveira ER, et al. Performance of the waist-to-height ratio in identifying obesity and predicting non-communicable diseases in the elderly population: a systematic literature review. Arch Gerontol Geriatr. 2016;65:174–182.
   PubMed Web of Science ®Google Scholar
• Deng G, Yin L, Liu W, China Investigator Team, et al. Associations of anthropometric adiposity indexes with hypertension risk: a systematic review and meta-analysis including PURE-China. Medicine (Baltimore). 2018;97(48):e13262.
   PubMed Web of Science ®Google Scholar
• Chang Y, Guo X, Li T, et al. A body shape index and body roundness index: two new body indices to identify left ventricular hypertrophy among rural populations in northeast China. Heart Lung Circ. 2016;25(4):358–364.
   PubMed Web of Science ®Google Scholar
• Zhang N, Chang Y, Guo X, et al. A body shape index and body roundness index: two new body indices for detecting association between obesity and hyperuricemia in rural area of China. Eur J Intern Med. 2016;29:32–36.
   PubMed Web of Science ®Google Scholar